HBI Deals+Insights / Digital and AI
The sale of genetics-led consumer healthcare and biotech company 23andMe has taken an unexpected turn, with bidding reopened and its co-founder and former CEO Anne Wojcicki putting in a nearly $50 million higher offer than the previously confirmed buyer.





